JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 2 |
AT&T
T
|
+$543M |
| 3 |
Boston Scientific
BSX
|
+$534M |
| 4 |
McDonald's
MCD
|
+$493M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$445M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
Broadcom
AVGO
|
+$618M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$511M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.58% |
| 2 | Financials | 12.98% |
| 3 | Technology | 10.83% |
| 4 | Healthcare | 10.56% |
| 5 | Consumer Discretionary | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ENIA
2626
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $2.14M | ﹤0.01% |
249,469
+191,823
| +333% | +$1.53M |
2015 Q4
2 quarters
|
|
|
UBNK
2627
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.14M | ﹤0.01% |
164,775
-7,000
| -4% | -$90.8K |
2013 Q2
12 quarters
|
|
2628
Federated Hermes
FHI
$4.23B
| $2.14M | ﹤0.01% |
74,285
+13,106
| +21% | +$401K |
2013 Q2
12 quarters
|
|
2629
PUT
Travel + Leisure Co
TNL
$3.87B
| $2.14M | ﹤0.01% |
+66,450
| New | +$2.13M |
2016 Q2
0 quarters
|
|
2630
Southern Copper
SCCO
$175B
| $2.13M | ﹤0.01% |
86,356
-31,627
| -27% | -$791K |
2013 Q2
12 quarters
|
|
|
AGTC
2631
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.13M | ﹤0.01% |
150,798
-12,791
| -8% | -$200K |
2014 Q2
8 quarters
|
|
2632
Franklin Electric
FELE
$4.34B
| $2.13M | ﹤0.01% |
64,383
+8,573
| +15% | +$280K |
2013 Q2
12 quarters
|
|
2633
Future Fuel
FF
$223M
| $2.12M | ﹤0.01% |
194,854
-236,240
| -55% | -$2.59M |
2013 Q2
12 quarters
|
|
|
APOL
2634
DELISTED
Apollo Education Group Inc Class A
APOL
| $2.12M | ﹤0.01% |
231,944
-35,006
| -13% | -$302K |
2013 Q2
12 quarters
|
|
2635
Credit Acceptance
CACC
$5.54B
| $2.11M | ﹤0.01% |
11,420
-591
| -5% | -$108K |
2013 Q2
12 quarters
|
|
2636
iShares Intermediate Government/Credit Bond ETF
GVI
$3.74B
| $2.11M | ﹤0.01% |
18,587
-3,642
| -16% | -$408K |
2013 Q2
12 quarters
|
|
|
PCBK
2637
DELISTED
Pacific Continental Corp
PCBK
| $2.1M | ﹤0.01% |
133,684
-6,292
| -4% | -$103K |
2013 Q2
12 quarters
|
|
2638
Central Garden & Pet Co
CENT
$2.48B
| $2.08M | ﹤0.01% |
113,656
+99,120
| +682% | +$1.45M |
2015 Q4
2 quarters
|
|
2639
Bio-Rad Laboratories Class A
BIO
$9.76B
| $2.07M | ﹤0.01% |
14,457
-18,922
| -57% | -$2.7M |
2013 Q2
12 quarters
|
|
2640
First Trust Multi Cap Value AlphaDEX Fund
FAB
$160M
| $2.06M | ﹤0.01% |
48,364
-12,757
| -21% | -$546K |
2013 Q2
12 quarters
|
|
2641
CALL
Medtronic
MDT
$112B
| $2.06M | ﹤0.01% |
+23,762
| New | +$1.92M |
2016 Q2
0 quarters
|
|
|
QTS
2642
DELISTED
QTS REALTY TRUST, INC.
QTS
| $2.05M | ﹤0.01% |
36,636
-17,159
| -32% | -$884K |
2015 Q1
5 quarters
|
|
2643
Vanguard Morningstar Growth ETF
VUG
$236B
| $2.05M | ﹤0.01% |
114,780
+6,246
| +6% | +$111K |
2013 Q2
12 quarters
|
|
|
CLC
2644
DELISTED
Clarcor
CLC
| $2.05M | ﹤0.01% |
33,676
+4,492
| +15% | +$263K |
2014 Q1
9 quarters
|
|
|
VIAB
2645
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $2.05M | ﹤0.01% |
49,382
+46,882
| +1,875% | +$1.94M |
2016 Q1
1 quarter
|
|
|
TVRD
2646
Tvardi Therapeutics
TVRD
$15.6M
| $2.04M | ﹤0.01% |
11,802
-2,459
| -17% | -$535K |
2014 Q1
9 quarters
|
|
2647
Integra LifeSciences
IART
$1.05B
| $2.04M | ﹤0.01% |
51,134
+12,340
| +32% | +$444K |
2014 Q4
6 quarters
|
|
2648
Phibro Animal Health
PAHC
$1.51B
| $2.04M | ﹤0.01% |
109,281
+109,065
| +50,493% | +$2.27M |
2014 Q2
8 quarters
|
|
|
AIQ
2649
DELISTED
Alliance Healthcare Services
AIQ
| $2.04M | ﹤0.01% |
326,245
-152,230
| -32% | -$1.04M |
2015 Q1
5 quarters
|
|
2650
Atara Biotherapeutics
ATRA
$86.3M
| $2.03M | ﹤0.01% |
3,605
+1,101
| +44% | +$528K |
2014 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2016 Portfolio in Review
As of Q2 2016, JP Morgan Chase held 5,277 positions worth $401B, up 2.7% from $391B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2016 filing shows 543 new, 2,005 increased, 1,674 reduced and 446 closed positions. Its largest new stake was S&P Global: 3,576,026 shares worth $384M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2016 buy was S&P Global: 3,576,026 shares worth $384M.
- JP Morgan Chase added most to Alphabet (Google) Class A in Q2 2016, an estimated $561M increase.
- JP Morgan Chase's biggest Q2 2016 reduction was Apple, cutting an estimated $916M.
- JP Morgan Chase fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $1.03B.
- JP Morgan Chase's ten largest holdings make up 16% of its $401B portfolio in Q2 2016.
- JP Morgan Chase opened 543 new positions and closed 446 in Q2 2016.
- JP Morgan Chase's portfolio value rose 2.7% quarter-over-quarter to $401B.
Based on JP Morgan Chase's 13F filing for Q2 2016, filed 8 Aug 2016.